In this series, experts discuss best practices for clinical use of onabotulinumtoxinA in the managements of overactive bladder.
EP. 1: Optimizing onabotA for OAB: What are some common misconceptions?
“Like any disease state, you want to make sure you have the right diagnosis; otherwise, you're not going to have a successful treatment plan," says Karyn S. Eilber, MD.
EP. 2: Karyn S. Eilber, MD, on patient counseling for onabotA treatment for OAB
The use of onabotulinumtoxinA (onabotA, Botox) for the treatment of overactive bladder comes with several important considerations.
EP. 3: Administering onabotA: Improving patient comfort and easing anxiety
An expert walks through specific actions that urologists and their teams can take before, during, and after the procedure.
EP. 4: Considerations for patient follow-up after onabotA administration
An expert details key post-procedural recommendations following onabotulinumtoxinA injection for OAB.
Expert discusses the promise of emerging MISTs for BPH
Study results show CVAC 2.0 is safe, efficacious for wide range of kidney stones
FDA Advisory Committee unanimously votes against talazoparib plus enzalutamide for mCRPC
FDA Advisory Committee finds evidence for UGN-102 inconclusive, cites uncertainty in benefit-risk